Found: 2
Select item for more details and to access through your institution.
Exome-Based Genomic Markers Could Improve Prediction of Checkpoint Inhibitor Efficacy Independently of Tumor Type.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 8, p. 7592, doi. 10.3390/ijms24087592
- By:
- Publication type:
- Article
Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 3020, doi. 10.3390/cancers13123020
- By:
- Publication type:
- Article